X @Bloomberg

Drug Development - Novo Nordisk's oral Ozempic for Alzheimer's showed biological response in some areas despite failed trials [1] - The company is considering further research on the pill version of Ozempic for Alzheimer's [1] Clinical Trial Outcomes - Alzheimer's patients in the trials did not experience cognitive improvement [1]